Cannabis

Walmart is looking into selling cannabis products in its Canadian stores

Walmart
Wal-mart's Canadian stores are looking into carrying marijuana-infused products. Reuters
Read in app

Walmart may be the next big retailer to get into the marijuana business.

The big-box retailer's Canadian division told Bloomberg it has carried out some "preliminary fact-finding" on potentially carrying CBD (or cannabidiol) infused products, but has no plans to do so yet. Walmart's stock was up 2% following the reports.

CBD is a non-psychoactive component of marijuana that's linked to a range of health benefits but can't get you high.

Canada is set to legalize marijuana federally on October 17In the US, the CBD market is estimated to be a $1 billion business, and some analysts believe the market could explode to $22 billion across a range of categories, including beverages, snacks, and beauty products, in the next four years.

Coca-Cola is reportedly eyeing a deal with Aurora Cannabis to produce beverages infused with CBD for the Canadian market. Constellation Brands — the beermaker behind Corona and Modelo — recently paid $4 billion for a 38% stake in the Canadian cultivator Canopy Growth.

On top of that, Lagunitas, Heineken's popular California-based brand, recently developed a hoppy, THC-infused sparkling water. And Molson Coors recently entered a joint venture with Hexo, a publicly-traded cultivator, to produce marijuana-infused beer for the Canadian market. 

"Health and wellness consumers are beginning to find value and use cases from CBD-based oil extracts, tinctures, topicals and capsules to improve everyday life," Vivien Azer, an analyst at the investment bank Cowen said in a note on Tuesday.

"We expect to see CBD used as a functional ingredient in non-alcoholic beverages," Azer said. 

Read more of our cannabis industry coverage:

Read next

Jeremy is the founder and editor-in-chief of Cultivated Media, a newsletter bringing readers inside the emerging cannabis industry. Beyond his reporting, Jeremy is studying for his MBA at Columbia Business School and holds a certificate in cannabis pharmacology from the University of Vermont where he studied as a cannabis media fellow. Jeremy was formerly a senior reporter at Insider where he focused on the cannabis industryJeremy has covered the bumpy rollout of Canada's cannabis legalization, the boom in cannabis companies going public (and the resulting fallout), multibillion-dollar mergers between cannabis companies and corporations from other industries, the ongoing health effects from vaporizers, the mislabeling of CBD products, and how the world's largest financial, legal, and political institutions are reacting to and planning for legalization. He has also gotten scoops and broken news on layoffs affecting cannabis companies, startups raising money, banks and law firms building specialized cannabis practices, tracked which companies and individuals are profiting from cannabis, and profiled some of the top executives, investors, and leaders in the industry.He is a sought-after expert on cannabis business and policy, frequently speaking to the media and at industry conferences.